ReviewCells2022
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.
Catherine Hottin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewCells2022
Catherine Hottin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.